These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 25780303

  • 1. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ, Zheng JS, Cui SC, Cui XW, Hu CX, Fang D, Ye LC.
    World J Gastroenterol; 2015 Mar 14; 21(10):3035-40. PubMed ID: 25780303
    [Abstract] [Full Text] [Related]

  • 2. Comparison of diagnostic sensitivity of C-arm CT, DSA and CT in detecting small HCC.
    Zheng J, Li J, Cui X, Ye H, Ye L.
    Hepatogastroenterology; 2013 Sep 14; 60(126):1509-12. PubMed ID: 23665467
    [Abstract] [Full Text] [Related]

  • 3. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
    Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI.
    AJR Am J Roentgenol; 2013 Sep 14; 201(3):675-83. PubMed ID: 23971463
    [Abstract] [Full Text] [Related]

  • 4. Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography.
    Iwazawa J, Ohue S, Mitani T, Abe H, Hashimoto N, Hamuro M, Nakamura K.
    AJR Am J Roentgenol; 2009 Apr 14; 192(4):1057-63. PubMed ID: 19304714
    [Abstract] [Full Text] [Related]

  • 5. C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma.
    Iwazawa J, Ohue S, Kitayama T, Sassa S, Mitani T.
    AJR Am J Roentgenol; 2011 Aug 14; 197(2):W337-42. PubMed ID: 21785062
    [Abstract] [Full Text] [Related]

  • 6. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K, Numata K, Morimoto M, Kondo M, Nozaki A, Moriya S, Ishii T, Oshima T, Fukuda H, Okada M, Takebayashi S, Maeda S, Tanaka K.
    Eur J Radiol; 2013 Sep 14; 82(9):1471-80. PubMed ID: 23769188
    [Abstract] [Full Text] [Related]

  • 7. Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization.
    Liu FY, Li X, Yuan HJ, Guan Y, Wang MQ.
    Chin Med J (Engl); 2018 Oct 20; 131(20):2410-2416. PubMed ID: 30334525
    [Abstract] [Full Text] [Related]

  • 8. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z, Chen R, Duran R, Zhao Y, Yenokyan G, Chapiro J, Schernthaner R, Radaelli A, Lin M, Geschwind JF.
    Cardiovasc Intervent Radiol; 2015 Dec 20; 38(6):1548-56. PubMed ID: 26001366
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization.
    Kakeda S, Korogi Y, Ohnari N, Moriya J, Oda N, Nishino K, Miyamoto W.
    J Vasc Interv Radiol; 2007 Dec 20; 18(12):1508-16. PubMed ID: 18057285
    [Abstract] [Full Text] [Related]

  • 10. The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.
    Du F, Jiang R, Gu M, He C, Guan J.
    Radiol Med; 2015 Aug 20; 120(8):690-4. PubMed ID: 25698303
    [Abstract] [Full Text] [Related]

  • 11. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
    Liu QY, He CD, Zhou Y, Huang D, Lin H, Wang Z, Wang D, Wang JQ, Liao LP.
    World J Gastroenterol; 2016 Mar 21; 22(11):3242-51. PubMed ID: 27004002
    [Abstract] [Full Text] [Related]

  • 12. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.
    Herber S, Biesterfeld S, Franz U, Schneider J, Thies J, Schuchmann M, Düber C, Pitton MB, Otto G.
    Cardiovasc Intervent Radiol; 2008 Mar 21; 31(4):768-77. PubMed ID: 18196335
    [Abstract] [Full Text] [Related]

  • 13. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R, Otto G, Biesterfeld S, Oberholzer K, Dueber C, Pitton MB.
    Cardiovasc Intervent Radiol; 2010 Jun 21; 33(3):532-40. PubMed ID: 19847482
    [Abstract] [Full Text] [Related]

  • 14. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.
    Irie T, Kuramochi M, Takahashi N.
    Cardiovasc Intervent Radiol; 2013 Jun 21; 36(3):706-13. PubMed ID: 22996589
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM, Gao ZL, Lyu XT, Jia J, Zhu P, Chen Y, Liu YL, Zhang ZX.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun 20; 26(6):429-435. PubMed ID: 30317756
    [Abstract] [Full Text] [Related]

  • 16. Clinical utility and limitations of tumor-feeder detection software for liver cancer embolization.
    Iwazawa J, Ohue S, Hashimoto N, Muramoto O, Mitani T.
    Eur J Radiol; 2013 Oct 20; 82(10):1665-71. PubMed ID: 23743053
    [Abstract] [Full Text] [Related]

  • 17. Cone-Beam CT-Guided Chemoembolization in Patients with Complete Response after Previous Chemoembolization but Subsequent Elevated α-Fetoprotein without Overt Hepatocellular Carcinoma.
    Wattanasatesiri T, Kim HC, Choi JW, Lee JH, Joo I, Hur S, Lee M, Jae HJ, Chung JW.
    J Vasc Interv Radiol; 2019 Aug 20; 30(8):1273-1280. PubMed ID: 31235410
    [Abstract] [Full Text] [Related]

  • 18. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients.
    Hayashi K, Ina H, Tezuka M, Okada Y, Irie T.
    Cardiovasc Intervent Radiol; 2007 Aug 20; 30(6):1144-55. PubMed ID: 17909884
    [Abstract] [Full Text] [Related]

  • 19. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
    Shim JH, Han S, Shin YM, Yu E, Park W, Kim KM, Lim YS, Lee HC.
    J Vasc Interv Radiol; 2013 Mar 20; 24(3):316-25. PubMed ID: 23312990
    [Abstract] [Full Text] [Related]

  • 20. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
    Duan F, Wang EQ, Lam MG, Abdelmaksoud MH, Louie JD, Hwang GL, Kothary N, Kuo WT, Hofmann LV, Sze DY.
    Radiology; 2016 Feb 20; 278(2):612-21. PubMed ID: 26334787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.